KAZIA THERAPEUTICS LTD's ticker is KZIA and the CUSIP is 48669G105. A total of 17 filers reported holding KAZIA THERAPEUTICS LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $368,000 | +60.0% | 32,435 | -15.6% | 0.04% | +7.1% |
| Q3 2020 | $230,000 | +113.0% | 38,435 | +18.5% | 0.04% | +82.6% |
| Q2 2020 | $108,000 | +17.4% | 32,435 | 0.0% | 0.02% | +4.5% |
| Q1 2020 | $92,000 | -35.2% | 32,435 | 0.0% | 0.02% | -24.1% |
| Q4 2019 | $142,000 | +47.9% | 32,435 | 0.0% | 0.03% | +38.1% |
| Q3 2019 | $96,000 | – | 32,435 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atom Investors LP | 99,180 | $857,000 | 0.09% |
| HighPoint Advisor Group LLC | 32,435 | $368,000 | 0.04% |
| Transform Wealth, LLC | 106,245 | $95,000 | 0.02% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 19,600 | $170,000 | 0.00% |
| Renaissance Technologies | 79,625 | $688,000 | 0.00% |
| TRUIST FINANCIAL CORP | 35,260 | $304,000 | 0.00% |
| UBS Group AG | 2,851 | $25,000 | 0.00% |
| BREWIN DOLPHIN LTD | 32 | $276 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 5 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 2,800 | $24,000 | 0.00% |